1
Back
C

Clinical Pharmacology and Therapeutics

IF5.5
Papers8636
Citations19410
Journal Papers 18350
Publication Date
delete
Physiologically Motivated Sequential Population Modeling of Albumin Trends and Vedolizumab Pharmacokinetics for Pregnancy Dosing Regimen Optimization
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-12-14
delete0
deleteOAAI
deleteZrinka Duvnjak; Robin Michelet; Casper Steenholdt; Ella S.K. Widigson; Cæcilie Skejø; João A. Abrantes; Wilhelm Huisinga; Mette Julsgaard; Charlotte Kloft
deleteShare
deleteSave
Navigating the Genetic Risk of Chemotherapy-Induced Hearing Loss in the Stria Vascularis
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-12-05
delete0
deleteOAAI
deleteTara Lazetic; Deanne Nixie R. Miao; Britt I. Drögemöller; Alain Dabdoub; Julia M. Abitbol
deleteShare
deleteSave
Real-World Effectiveness and Safety of Recombinant Human Follicle-Stimulating Hormone (rhFSH) in Infertile Women undergoing Assisted Reproductive Technology (ART): A Korean Nationwide Cohort Study
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-12-02
delete0
deleteOAAI
deleteJoong Yeup Lee; Eun-Young Choi; Jung Ryeol Lee; Young Sik Choi; Ji Hyang Kim; Chang-Woo Choo; Yunju Choe; Hee-Jin Seo; Hyesung Lee; Yujeong Shin; Yejin Jeon; Ju-Young Shin; Hoon Kim
deleteShare
deleteSave
Long-Read Sequencing Enhances Pharmacogenomic Profiling by Resolving Complex Haplotypes, Novel Star Alleles, and Structural Variants
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-27
delete0
PREAI
deleteSumudu Rangika Samarasinghe; Andrea Gaedigk; Jesse J. Swen; Henk-Jan Guchelaar; Shivashankar H. Nagaraj
deleteShare
deleteSave
Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-25
delete0
deleteOAAI
deleteWan-Yu Chu; Om Prakash Singh; Shyam Sundar; Dinesh Mondal; Krishna Pandey; Pradeep Das; Ignace C. Roseboom; Sheeraz Raja; Ana Torres; Eugenia Carrillo; Alwin D.R. Huitema; Fabiana Alves; Thomas P.C. Dorlo
deleteShare
deleteSave
Endpoint Exposure-Response Analyses in the Presence of Concurrent Dose Modification During Clinical Trials
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-25
delete0
PREAI
deleteRui Zhong; Yanguang Cao
deleteShare
deleteSave
Breaking Barriers: Characterization of the Intradermal Lipopolysaccharide Challenge as an In Vivo Model for Controlled Induction of Vascular Leakage in Healthy Volunteers
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-15
delete0
deleteOAAI
deleteMarella Cornelia Elizabeth van Ruissen; Menno van Diemen; Liza Botros; Ingrid Tomljanovic; Hind Achbo; Dimitra Eleftheriou; Paul Willem Schenk; Naomi Bertine Klarenbeek; Derek William Gilroy; Manon Aleida Adriana Jansen; Matthijs Moerland
deleteShare
deleteSave
Cystatin C-based eGFR better predicts renal vancomycin clearance than creatinine-based eGFR in patients with allogeneic stem cell transplantation
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-12
delete0
deleteOAAI
deleteEva-Maria A. Wansing; Sebastian G. Wicha; Peter Bannas; Alexander Heitkamp; Adrin Dadkhah; Nicolaus M. Kröger; Isabel Molwitz; Claudia Langebrake
deleteShare
deleteSave
Enhancing Severe Neutropenia Prediction: PKPD-Informed Labeling for Machine Learning Models Trained on Real-World Data
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-10
delete0
deleteOAAI
deleteConor J O’Hanlon; Jonas Denck; Elif Ozkirimli; Stefanie Bendels; Candice Jamois; Clarisse Chavanne; Dirk Fey; Kimmo Porkka; Oscar Brück; Ken Wang
deleteShare
deleteSave
Home Is Where the Research Is: The Promise of Decentralized Clinical Trials
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-09
delete0
deleteOAAI
deleteSarah A. Holstein
deleteShare
deleteSave
Drug-Induced QT Prolongation: Associations Between Risk Classifications in a Swedish Clinical Decision Support System and Clinical Outcomes
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-09
delete0
deleteOAAI
deleteOla Nordqvist; Olof Björneld; Patrick Bergman; Björn Wettermark; Alisa Lincke; Marine L. Andersson; Tora Hammar
deleteShare
deleteSave
Respiratory Disorders Associated with Antibody–Drug Conjugates: A Combined Analysis of the French and the WHO Pharmacovigilance Databases
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-07
delete0
PREAI
deleteVictor Mirleau; Alex Hlavaty; Etienne-Marie Jutant; Florence Hennegrave; Kévin Bihan; Romane Freppel; Clément Cholle; Delphine Bourneau-Martin; Claire Lafay-Chebassier; Julien Mahé; Matthieu Bainaud; Marion Allouchery
deleteShare
deleteSave
Evolving Standards: Good Clinical Practice Insights from US FDA, MHRA UK, and Health Canada
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-05
delete0
PREAI
deleteCheryl Grandinetti; Mandy Budwal-Jagait; Hocine Abid; Emily Gebbia; Elena Boley; LaKisha Williams; Andrew Fisher; Leigh Marcus; Laurie Muldowney; Jenn Sellers; Jason Wakelin-Smith; Kassa Ayalew
deleteShare
deleteSave
Insights Into Aldosterone Regulation Through Pharmacokinetic–Pharmacodynamic Modeling of an Aldosterone Synthase Inhibitor
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-05
delete0
PREAI
deleteJaviera Cortés-Ríos; William J. Jusko
deleteShare
deleteSave
Model-Informed Deep Q-Networks to Guide Infliximab Dosing in Pediatric Crohn’s Disease
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-05
delete0
deleteOAAI
deleteKei Irie; Phillip Minar; Jack Reifenberg; Brendan M. Boyle; Joshua D. Noe; Jeffrey S. Hyams; Tomoyuki Mizuno
deleteShare
deleteSave
Toward a More accurate, Evidence-Based Classification of CYP Inhibitors: A Critical Appraisal of Current Systems
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-04
delete0
deleteOAAI
deleteJanne T. Backman
deleteShare
deleteSave
Dual Minimal Physiologically Based Pharmacokinetic Model of Tenofovir Alafenamide and Its Metabolites in Humans
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-11-03
delete0
PREAI
deleteWeihua Jiang; Sukyung Woo
deleteShare
deleteSave
Model-Informed Drug Development for Daprodustat Supports the Design of Individualized Dosing Regimens in Chronic Kidney Disease Patients With Anemia
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-10-31
delete0
deleteOAAI
deleteKelly M. Mahar; Shuying Yang; Brendan Johnson; Sandra A.G. Visser; Paul van den Berg; Martijn van Noort; Teun M. Post
deleteShare
deleteSave
Biomarker Utilization for Regulatory Decision Making: A Landscape Analysis of Neurological Drug Products Approved by FDA (2008–2024)
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-10-30
delete0
PREAI
deleteDahee Jung; Sreedharan Sabarinath; Ramana Uppoor; Mehul Mehta; Yifei Zhang
deleteShare
deleteSave
A Fast Path from Innovation to Safe and Effective Medicine
deleteClinical Pharmacology & Therapeutics
IF5.5
delete2025-10-28
delete0
deleteOAAI
deletePeter Arlett; Falk Ehmann; Ralf Herold; Evdokia Korakianiti; Pierpaolo Moscariello; Liese Barbier; Iordanis Gravanis; Frank Pétavy; Emmanuel Cormier; Andrew Thomson; Spiros Vamvakas; Steffen Thirstrup
deleteShare
deleteSave